5 References

  • 1
    Moshfegh, A., Goldman, J., Cleveland, L., What we eat in America, NHANES 2001–2002: usual nutrient intakes from food compared to dietary reference intakes. U.S. Department of Agriculture, Agricultural Research Service, 2005.
  • 2
    Bailey, R. L., Fulgoni, V. L., Keast, D. R., Dwyer, J. T., Examination of vitamin intakes among US adults by dietary supplement use. J. Acad. Nutr. Dietetics 2012, 112, 657663.
  • 3
    Miller, A., Popular but dangerous: 3 vitamins that can hurt you if you take a vitamin pill, these warnings probably apply to you. U.S. News & World Report LP, 2012, Available from: Accessed: November 10, 2013.
  • 4
    Miller, E. R., Paston-Barriuso, R., Dalal, D., Riemersma, R. A., et al., Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann. Intern. Med. 2005, 142, 3746.
  • 5
    Myung, S. K., Ju, W., Cho, B., Oh, S. W. et al., Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic review and meta-analysis of randomised controlled trials. BMJ 2013, 346, f10.
  • 6
    Bjelakovic, G., Nikolova, D., Gluud, L. L., Simonetti, R. G., Gluud, C., Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst. Rev. 2012, 3, CD007176.
  • 7
    Lee, I. M., Cook, N. R., Gaziano, J. M., Gordon, D. et al., Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. JAMA 2005, 294, 5665.
  • 8
    Lonn, E., Bosch, J., Yusuf, S., Sheridan, P. et al., Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 2005, 293, 13381347.
  • 9
    Sesso, H. D., Buring, J. E., Christen, W. G., Kurth, T. et al., Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians’ Health Study II randomized controlled trial. JAMA 2008, 300, 21232133.
  • 10
    Schurks, M., Glynn, R. J., Rist, P. M., Tzourio, C. et al., Effects of vitamin E on stroke subtypes: meta-analysis of randomised controlled trials. BMJ 2010, 341, c5702.
  • 11
    Wheldon, G. H., Bhatt, A., Keller, P., Hummler, H., d,1-Alpha-tocopheryl acetate (vitamin E): a long term toxicity and carcinogenicity study in rats. Int. J. Vitam. Nutr. Res. 1983, 53, 287296.
  • 12
    Abdo, K. M., Rao, G., Montgomery, C. A., Dinowitz, M. et al., Thirteen-week toxicity study of d-alpha-tocopheryl acetate (vitamin E) in Fischer 344 rats. Food Chem. Toxicol. 1986, 24, 10431050.
  • 13
    Takahashi, O., Ichikawa, H., Sasaki, M., Hemorrhagic toxicity of d-alpha-tocopherol in the rat. Toxicology 1990, 63, 157165.
  • 14
    Frank, J., Weiser, H., Biesalski, H. K., Interaction of vitamins E and K: effect of high dietary vitamin E on phylloquinone activity in chicks. Int. J. Vitam. Nutr. Res. 1997, 67, 242247.
  • 15
    Helson, L., The effect of intravenous vitamin E and menadiol sodium diphosphate on vitamin K dependent clotting factors. Thromb. Res. 1984, 35, 1118.
  • 16
    Woolley, D. W., Biological antagonisms between metabolically important compounds and their structural analogs. Harvey Lect. 1945, 41, 189215.
  • 17
    March, B. E., Wong, E., Seier, L., Sim, J. et al., Hypervitaminosis E in the chick. J. Nutr. 1973, 103, 371377.
  • 18
    Food and Nutrition Board, Institute of Medicine, Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids, National Academy Press, Washington 2000.
  • 19
    Booth, S. L., Golly, I., Sacheck, J. M., Roubenoff, R. et al., Effect of vitamin E supplementation on vitamin K status in adults with normal coagulation status. Am. J. Clin. Nutr. 2004, 80, 143148.
  • 20
    Glynn, R. J., Ridker, P. M., Goldhaber, S. Z., Zee, R. Y. et al., Effects of random allocation to vitamin E supplementation on the occurrence of venous thromboembolism: report from the Women's Health Study. Circulation 2007, 116, 14971503.
  • 21
    Shearer, M. J., Newman, P., Recent trends in the metabolism and cell biology of vitamin K with special reference to vitamin K cycling and MK-4 biosynthesis. J. Lipid Res. 2014, 55, 345362.
  • 22
    Nakagawa, K., Hirota, Y., Sawada, N., Yuge, N. et al., Identification of UBIAD1 as a novel human menaquinone-4 biosynthetic enzyme. Nature 2010, 468, 117121.
  • 23
    Thijssen, H. H., Vervoort, L. M., Schurgers, L. J., Shearer, M. J., Menadione is a metabolite of oral vitamin K. Br. J. Nutr. 2006, 95, 260266.
  • 24
    Hirota, Y., Tsugawa, N., Nakagawa, K., Suhara, Y. et al., Menadione (vitamin K3) is a catabolic product of oral phylloquinone (vitamin K1) in the intestine and a circulating precursor of tissue menaquinone-4 (vitamin K2) in rats. J. Biol. Chem. 2013, 288, 3307133080.
  • 25
    Lamon-Fava, S., Sadowski, J. A., Davidson, K. W., O'Brien, M. E. et al., Plasma lipoproteins as carriers of phylloquinone (vitamin K1) in humans. Am. J. Clin. Nutr. 1998, 67, 12261231.
  • 26
    Erkkila, A. T., Lichtenstein, A. H., Dolnikowski, G. G., Grusak, M. A. et al., Plasma transport of vitamin K in men using deuterium-labeled collard greens. Metabolism 2004, 53, 215221.
  • 27
    Okano, T., Shimomura, Y., Yamane, M., Suhara, Y. et al., Conversion of phylloquinone (Vitamin K1) into menaquinone-4 (Vitamin K2) in mice: two possible routes for menaquinone-4 accumulation in cerebra of mice. J. Biol. Chem. 2008, 283, 1127011279.
  • 28
    Horie-Inoue, K., Inoue, S., Steroid and xenobiotic receptor mediates a novel vitamin K2 signaling pathway in osteoblastic cells. J. Bone Miner. Metab. 2008, 26, 912.
  • 29
    Fredericks, W. J., McGarvey, T., Wang, H., Zheng, Y. et al., The TERE1 protein interacts with mitochondrial TBL2: regulation of trans-membrane potential, ROS/RNS and SXR target genes. J. Cell. Biochem. 2013, 114, 21702187.
  • 30
    McGarvey, T. W., Nguyen, T., Tomaszewski, J. E., Monson, F. C. et al., Isolation and characterization of the TERE1 gene, a gene down-regulated in transitional cell carcinoma of the bladder. Oncogene 2001, 20, 10421051.
  • 31
    Mugoni, V., Postel, R., Catanzaro, V., De Luca, E. et al., Ubiad1 is an antioxidant enzyme that regulates eNOS activity by CoQ10 synthesis. Cell 2013, 152, 504518.
  • 32
    Nickerson, M. L., Bosley, A. D., Weiss, J. S., Kostiha, B. N. et al., The UBIAD1 prenyltransferase links menaquinone-4 [corrected] synthesis to cholesterol metabolic enzymes. Hum. Mutat. 2013, 34, 317329.
  • 33
    Fredericks, W. J., Sepulveda, J., Lai, P., Tomaszewski, J. E. et al., The tumor suppressor TERE1 (UBIAD1) prenyltransferase regulates the elevated cholesterol phenotype in castration resistant prostate cancer by controlling a program of ligand dependent SXR target genes. Oncotarget 2013, 4, 10751092.
  • 34
    Ferland, G., The discovery of vitamin K and its clinical applications. Ann. Nutr. Metab. 2012, 61, 213218.
  • 35
    Buitenhuis, H. C., Soute, B. A., Vermeer, C., Comparison of the vitamins K1, K2 and K3 as cofactors for the hepatic vitamin K-dependent carboxylase. Biochim. Biophys. Acta 1990, 1034, 170175.
  • 36
    Rishavy, M. A., Berkner, K. L., Vitamin K oxygenation, glutamate carboxylation, and processivity: defining the three critical facets of catalysis by the vitamin K-dependent carboxylase. Adv. Nutr. 2012, 3, 135148.
  • 37
    Vermeer, C., Vitamin K: the effect on health beyond coagulation—an overview. Food Nutr. Res. 2012, 56, doi: 10.3402/fnr.v56i0.5329.
  • 38
    Rishavy, M. A., Hallgren, K. W., Wilson, L. A., Usubalieva, A. et al., The vitamin K oxidoreductase is a multimer that efficiently reduces vitamin K epoxide to hydroquinone to allow vitamin K-dependent protein carboxylation. J. Biol. Chem. 2013, 288, 3155631566.
  • 39
    Wu, S., Liu, S., Davis, C. H., Stafford, D. W. et al., A hetero-dimer model for concerted action of vitamin K carboxylase and vitamin K reductase in vitamin K cycle. J. Theor. Biol. 2011, 279, 143149.
  • 40
    Suhara, Y., Murakami, A., Nakagawa, K., Mizuguchi, Y. et al., Comparative uptake, metabolism, and utilization of menaquinone-4 and phylloquinone in human cultured cell lines. Bioorg. Med. Chem. 2006, 14, 66016607.
  • 41
    Chatrou, M. L., Reutelingsperger, C. P., Schurgers, L. J., Role of vitamin K-dependent proteins in the arterial vessel wall. Hamostaseologie 2011, 31, 251257.
  • 42
    Traber, M. G., Atkinson, J., Vitamin E, antioxidant and nothing more. Free Radic. Biol. Med. 2007, 43, 415.
  • 43
    Traber, M. G., Mechanisms for the prevention of vitamin E excess. J. Lipid Res. 2013, 54, 22952306.
  • 44
    McDonald, M. G., Rieder, M. J., Nakano, M., Hsia, C. K. et al., CYP4F2 is a vitamin K1 oxidase: an explanation for altered warfarin dose in carriers of the V433M variant. Mol. Pharmacol. 2009, 75, 13371346.
  • 45
    Edson, K. Z., Prasad, B., Unadkat, J. D., Suhara, Y. et al., Cytochrome P450-dependent catabolism of vitamin K: omega-hydroxylation catalyzed by human CYP4F2 and CYP4F11. Biochemistry 2013, 52, 82768285.
  • 46
    Harrington, D. J., Booth, S. L., Card, D. J., Shearer, M. J., Excretion of the urinary 5C- and 7C-aglycone metabolites of vitamin K by young adults responds to changes in dietary phylloquinone and dihydrophylloquinone intakes. J Nutr 2007, 137, 17631768.
  • 47
    Sontag, T. J., Parker, R. S., Cytochrome P450 omega-hydroxylase pathway of tocopherol catabolism. Novel mechanism of regulation of vitamin E status. J. Biol. Chem. 2002, 277, 2529025296.
  • 48
    Sontag, T. J., Parker, R. S., Influence of major structural features of tocopherols and tocotrienols on their omega-oxidation by tocopherol-omega-hydroxylase. J. Lipid Res. 2007, 48, 10901098.
  • 49
    Jiang, Q., Natural forms of vitamin E: metabolism, antioxidant and anti-inflammatory activities and the role in disease prevention and therapy. Free Radic. Biol. Med. 2014, 72C, 7690.
  • 50
    Farley, S. M., Leonard, S. W., Labut, E. M., Raines, H. F. et al., Vitamin E decreases extra-hepatic menaquinone-4 concentrations in rats fed menadione or phylloquinone. Mol. Nutr. Food Res. 2012, 56, 912922.
  • 51
    Farley, S. M., Leonard, S. W., Taylor, A. W., Birringer, M. et al., omega-Hydroxylation of phylloquinone by CYP4F2 is not increased by alpha-tocopherol. Mol. Nutr. Food Res. 2013, 57, 17851793.
  • 52
    Podda, M., Weber, C., Traber, M. G., Packer, L., Simultaneous determination of tissue tocopherols, tocotrienols, ubiquinols and ubiquinones. J. Lipid Res. 1996, 37, 893901.
  • 53
    Leonard, S. W., Traber, M. G., Measurement of the vitamin E metabolites, carboxyethyl hydroxychromans (CEHCs), in biological samples. Curr. Protoc. Toxicol. 2006, 29,
  • 54
    Li, Y. J., Luo, S. C., Lee, Y. J., Lin, F. J. et al., Isolation and identification of alpha-CEHC sulfate in rat urine and an improved method for the determination of conjugated alpha-CEHC. J. Agric. Food Chem. 2008, 56, 1110511113.
  • 55
    Al Rajabi, A., Booth, S. L., Peterson, J. W., Choi, S. W. et al., Deuterium-labeled phylloquinone has tissue-specific conversion to menaquinone-4 among Fischer 344 male rats. J. Nutr. 2012, 142, 841845.
  • 56
    Vatassery, G. T., Brin, M. F., Fahn, S., Kayden, H. J. et al., Effect of high doses of dietary vitamin E upon the concentrations of vitamin E in several brain regions, plasma, liver and adipose tissue of rats. J. Neurochem. 1988, 51, 621623.
  • 57
    Ingold, K. U., Burton, G. W., Foster, D. O., Hughes, L. et al., Biokinetics of and discrimination between dietary RRR- and SRR-alpha-tocopherols in the male rat. Lipids 1987, 22, 163172.
  • 58
    Schurgers, L. J., Vermeer, C., Differential lipoprotein transport pathways of K-vitamins in healthy subjects. Biochim. Biophys. Acta 2002, 1570, 2732.
  • 59
    Tovar, A., Ameho, C. K., Blumberg, J. B., Peterson, J. W. et al., Extrahepatic tissue concentrations of vitamin K are lower in rats fed a high vitamin E diet. Nutr. Metab. 2006, 3, 29.
  • 60
    Thijssen, H. H., Drittij-Reijnders, M. J., Vitamin K distribution in rat tissues: dietary phylloquinone is a source of tissue menaquinone-4. Br. J. Nutr. 1994, 72, 415425.
  • 61
    Thijssen, H. H., Drittij-Reijnders, M. J., Vitamin K status in human tissues: tissue-specific accumulation of phylloquinone and menaquinone-4. Br. J. Nutr. 1996, 75, 121127.
  • 62
    Niemeier, A., Niedzielska, D., Secer, R., Schilling, A. et al., Uptake of postprandial lipoproteins into bone in vivo: impact on osteoblast function. Bone 2008, 43, 230237.
  • 63
    Bharadwaj, K. G., Hiyama, Y., Hu, Y., Huggins, L. A. et al., Chylomicron- and VLDL-derived lipids enter the heart through different pathways: in vivo evidence for receptor- and non-receptor-mediated fatty acid uptake. J. Biol. Chem. 2010, 285, 3797637986.
  • 64
    Goldberg, I. J., Trent, C. M., Schulze, P. C., Lipid metabolism and toxicity in the heart. Cell Metab. 2012, 15, 805812.
  • 65
    Reboul, E., Borel, P., Proteins involved in uptake, intracellular transport and basolateral secretion of fat-soluble vitamins and carotenoids by mammalian enterocytes. Prog. Lipid Res. 2011, 50, 388402.
  • 66
    Podszun, M. C., Grebenstein, N., Spruss, A., Schlueter, T. et al., Dietary alpha-tocopherol and atorvastatin reduce high-fat-induced lipid accumulation and down-regulate CD36 protein in the liver of guinea pigs. J. Nutr. Biochem. 2014, 25, 573579.
  • 67
    Venugopal, S. K., Devaraj, S., Jialal, I., RRR-alpha-tocopherol decreases the expression of the major scavenger receptor, CD36, in human macrophages via inhibition of tyrosine kinase (Tyk2). Atherosclerosis 2004, 175, 213220.